European Journal of Cancer
Volume 39, Issue 13 , Pages 1818-1827, September 2003

Current research and treatment for epithelial ovarian cancer A Position Paper from the Helene Harris Memorial Trust☆☆

  • F. Balkwill

      Affiliations

    • Cancer Research UK, Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-20-7882-6106; fax: +44-20-7882-6110
  • ,
  • R.C. Bast Jr.

      Affiliations

    • Cancer Research UK, Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
  • ,
  • J. Berek

      Affiliations

    • Cancer Research UK, Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
  • ,
  • G. Chenevix-Trench

      Affiliations

    • Cancer Research UK, Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
  • ,
  • M. Gore

      Affiliations

    • Cancer Research UK, Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
  • ,
  • T. Hamilton

      Affiliations

    • Cancer Research UK, Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
  • ,
  • I. Jacobs

      Affiliations

    • Cancer Research UK, Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
  • ,
  • G. Mills

      Affiliations

    • Cancer Research UK, Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
  • ,
  • R. Souhami

      Affiliations

    • Cancer Research UK, Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
  • ,
  • N. Urban

      Affiliations

    • Cancer Research UK, Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
  • ,
  • S. Ursulic

      Affiliations

    • Cancer Research UK, Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
  • ,
  • J. Smyth

      Affiliations

    • Cancer Research UK, University of Edinburgh, Cancer Research Centre, Crewe Road South, Edinburgh EH4 2XR, UK

Received 5 June 2003; accepted 5 June 2003.

Abstract 

In March 2003, an international mulltidisciplinary group of scientists and clinicians with a specific interest in ovarian cancer met for 4 days to discuss research into and treatment of this challenging disease. Under the headings of molecular genetics, molecular biology, the biology of ovarian cancer, old therapies, new targets and the early detection of the disease, this Position Paper summarises the presentations and discussion from the 9th Biennial Helene Harris Memorial Trust Forum on Ovarian Cancer. In particular, we highlight the potential of international collaborations in translating laboratory science into useful clinical interventions.

Keywords:  Ovarian cancer, International collaboration, Early detection, New targets, Oeromic profiling, Transcriptional profiling

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Complete abstracts for the meeting and full addresses for the other authors (who chaired the individual sessions) are published on the HHMT website (). The names in bold refer to the speakers at the meeting and can also be found on the HHMT website.

☆☆ The Helene Harris Memorial Trust was founded in 1986 by John Harris and his family, in memory of John's wife Helene who died aged 48 years of ovarian cancer. The HHMT promotes and funds dialogue, debate and forums to advance research, diagnosis and treatment in the field of ovarian cancer (www.hhmt.org). The HHMT is collating information for a world-wide database to locate all researchers and clinicians in the field of ovarian cancer. Please send details to database@hhmt.org.

PII: S0959-8049(03)00511-2

doi:10.1016/S0959-8049(03)00511-2

Refers to erratum:

  • Erratum to “Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust” [European Journal of Cancer, 39 (2003) 1818–1827]

    F Balkwill, R.C Bast, J Berek, G Chenevix-Trench, M Gore, T Hamilton, I Jacobs, G Mills, R Souhami, N Urban, S Orsulic, J Smyth
    European Journal of Cancer March 2004 (Vol. 40, Issue 4, Page 628)

European Journal of Cancer
Volume 39, Issue 13 , Pages 1818-1827, September 2003